Daniels received his B.S. in Chemistry at The Ohio State University in 2003 after which he worked in the pharmaceutical industry at Abbott Laboratories and Hospira Inc. doing analytical chemistry research and development. In 2010 he received his Ph.D. in Chemistry from Vanderbilt University. His medicinal chemistry work centered on CNS drug discovery projects. Daniels then went on to do his postdoctoral work in the laboratory of Dr. Steve Fesik in the department of biochemistry at Vanderbilt University where he learned structure based drug design and fragment based approaches, in the field of cancer drug discovery. He now conducts drug discovery research at Lipscomb University College of Pharmacy while collaborating with his former advisor, Dr. Craig Lindsley in the Vanderbilt Center for Neuroscience Drug Discovery. Dr. Daniels’ research focuses on developing novel therapeutics for the treatment of Parkinson’s disease.